Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 23, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - July 23, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/15/17 - 5 Dangers of purchasing medicine online [Cape Community (South Africa)]
Picture: Indianexpress When it comes to drugs bought online, you never know exactly what you re getting. Online medicine buying certainly has its perks. It s quick, you can do it from anywhere, it circumvents discussions with medical professionals, and with fewer overheads, it s cheaper than shopping at regular pharmacies.
7/15/17 - Alder prices $150M offering to fund migraine market scrap [Arab News (Saudi Arabia)]
Alder Biopharmaceuticals has priced a $150 million follow-on offering. The stock sale will set Alder up to forge ahead with development of a migraine drug it thinks can carve out a space in a market fought over by larger rivals such as Amgen and Eli Lilly. Bothell, Washington- based Alder plans to use the money to finish a pivotal trial program for
7/15/17 - Alembic Pharma opens Rs 300 crore anti-cancer drug unit in Gujarat [Arab Times (Kuwait)]
Drug firm Alembic Pharmaceuticals Ltd today entered into oncology segment by inaugurating a Rs 300 crore anti-cancer drug facility at Halol in Gujarat. Gujarat Chief Minister Vijay Rupani after inaugurating plant said, " Gujarat is a leading producer with 80 per cent of pharmaceuticals products in the country and our government encourages more R&D.
7/15/17 - Allena claims orphan status for `devastating` rare disease therapy [Arab Finance (Egypt)]
Allena Pharma has been granted orphan status by the FDA for a drug to treat primary hyperoxaluria, a rare disease that causes kidney and bladder stones and can lead to kidney failure and death. The drugcalled ALLN-177is a non-absorbed formulation of an enzyme designed to break down a substance called oxalate in the gastrointestinal tract.
7/15/17 - AOP Orphan and PharmaEssentia announce latest clinical results for Ropeginterferon alfa-2b in Polycythemia Vera from 3 abstracts presented at the...
AOP Orphan and PharmaEssentia announce latest clinical results for Ropeginterferon alfa-2b in Polycythemia Vera from 3 abstracts presented at the 22nd Congress of the European Hematology Association EHA in Madrid. By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week AOP Orphan Pharmaceuticals AG and PharmaEssentia Corporation..
7/15/17 - AVEO Oncology Announces Positive CHMP Opinion for Tivozanib as a Treatment of Advanced Renal Cell Carcinoma
By a News Reporter-Staff News Editor at Marketing Weekly News AVEO Oncology announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has recommended FOTIVDA? for approval as a treatment for patients with advanced renal cell carcinoma. If approved by the EC, marketing authoriza
7/15/17 - AXELEAD Begins Operations [Sudan Tribune]
Takeda Pharmaceutical Company and Axcelead Drug Discovery Partners has announced the start of operations for AXCELEAD. This research will assist companies within and outside Japan as part of the firm`s comprehensive integrated drug discovery services and consultation for the Shonan Health Innovation Park at Takeda`s Shonan Research Center.
7/15/17 - But this money-or-your-life extortion racket isn't the root of the case against him
Louisiana is plagued by obesity, opioid addiction and other health crises. Hepatitis C destroys the liver, but the drugs to treat it cost $85,000 for a 12- week regimen. But Louisiana's health secretary has landed on a novel approach that other states are watching.
7/15/17 - Data from Oulu University Hospital Advance Knowledge in Anemia (The Effect of Preoperative Anemia on the Outcome After Coronary Surgery)
For more information on this research see: The Effect of Preoperative Anemia on the Outcome After Coronary Surgery. World Journal of Surgery, 2017; 41: 1910-1918. World Journal of Surgery can be contacted at: Springer, 233 Spring St, New York, NY 10013, USA. Our news journalists report that additional information may be obtained by contacting F. Bi
7/15/17 - Drug Regulatory Authority of Pakistan introduces software for monitoring of pharmaceuticals firms - Press Note issued by Drug Regulatory Authority of Pakistan
Following is the text of press note issued by Drug Regulatory Authority of Pakistan. Chief Executive Officer Drug Regulatory Authority of Pakistan Dr Mohammad Aslam inaugurated the software at DRAP Karachi Office. Chairman, Pakistan Pharmaceutical Manufacturers' Association, Dr Sheikh Kaisar Waheed, expressed gratitude for the initiative being take
7/15/17 - Drugs from overseas to get on fast track [Sudan Tribune]
China will continue to intensify international exchanges and cooperation in drug supervision to promote the domestic application of new medicines developed overseas to meet demand, China`s top drug regulator said on Thursday. Annual revenues of the pharmaceutical industry in China exceed 2.5 trillion yuan, and annual exports of pharmaceutical...
7/15/17 - EMA validates Gilead Sciences marketing application for BIC/FTC/TAF combination [Arab Times (Kuwait)]
During the Phase III clinical trials, BIC/ FTC/ TAF has shown high rates of virologic suppression and no treatment-emergent resistance through 48 weeks among treatment-nave adult patients, as well as virologically suppressed adult patients who switched regimens. Gilead Sciences chief scientific officer and research and development executive...
7/15/17 - FDA panel recommends new breakthrough gene therapy for B-cell acute lymphoblastic leukemia (ALL) [All Iraq News Agency (AIN)]
A Food and Drug Administration panel created history by recommending a gene therapy for patients with cancer. In this therapy the patients own genes would be modified to fight the cancer cells. The treatment was developed by scientists at the University of Pennsylvania and is licensed to Novartis.
7/15/17 - FDA recommends approval for Novartis CTL019 to treat r/r B-cell ALL [Syrian Arab News Agency]
The US Food and Drug Administrations Oncologic Drugs Advisory Committee has unanimously recommended approval of Novartis CTL019 for the treatment of relapsed or refractory B-cell acute lymphoblastic leukaemia. Novartis Oncology CEO Bruno Strigini said: The panel`s unanimous recommendation in favour of CTL019 moves us closer to potentially...
7/15/17 - Genetically Enhanced, Cord-Blood Derived Immune Cells Strike B-Cell Cancers
The University of Texas MD Anderson Cancer Center issued the following news release:. Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt down cells with specific targets on them to treat cancer, researchers at The University of Texas MD Anderson Cancer Center report
7/15/17 - Global Cardiovascular Peptides Market Share by Industry Research 2016 - 2024
Transparency Market Research Report Added "Cardiovascular Peptides Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016- 2024" Albany, NY 07/14/2017 Global Cardiovascular Peptides Market: OverviewPeptide therapeutics has been around for decades, but recently there has been an incease in interest of the pharmaceutica
7/15/17 - J&Js psoriasis drug faces crowded market after US approval [Sport360]
The FDA has backed guselkumab, which will be branded as Tremfya, for adults with moderate to severe plaque psoriasis. Valeant bought Siliq from AstraZeneca, which was keen to offload the drug after a risk suicidal ideation emerged in trials something that will likely affect the drugs marketability as the FDA insisted it carried a warning on its box
7/15/17 - Jamaica Cancer Drug Aims For Yearly US$250m Haul [T-break Tech (Middle East)]
Scientist and businessman Dr Henry Lowe is predicting annual sales of US $250 million, the equivalent of around $32 billion, from Cresorol, an anti-cancer drug made from marijuana. The product, which targets acute myeloid leukemia has been designated an `orphan drug` by the US Food and Drug Administration, the FDA, but the American regulator also n
7/15/17 - JAMAICA-MARIJUANA-Government will ensure standards are met in marijuana industry
Prime Minister Andrew Holness, says the Government will be exercising caution in how cannabis is leveraged in the development of Jamaica's nutraceutical industry. The Prime Minister was speaking at a ceremony to announce the United States Food and Drug Administration's award of Orphan Drug Status for' Chrysoeriol', which has been developed by Flavo
7/15/17 - Multifaceted Biotech Company Poised to Begin Trading on Canadian Securities Exchange [Arab News (Saudi Arabia)]
Shares of PreveCeutical Medical Inc. are expected to begin trading on the Canadian Securities Exchange on July 14 under the symbol PREV. In April, PreveCeutical formed a partnership with UniQuest Pty Limited at Queensland University in Australia. PreveCeutical CEO Stephen Van Deventer, in an interview with CFN Media Group, noted that "Through our r
7/15/17 - Novartis stellar CAR-T efficacy data steamrolls safety doubts to power landmark cancer therapy toward approval [Arab Times (Kuwait)]
Many of these issues will need close monitoring if, as expected, Novartis and, a little later, Kite Pharma bring CAR-T therapies to market. And some of the concerns provide opportunities for members of the chasing pack such as Juno Therapeutics and its defined cell composition product and Cellectis and its off-the-shelf candidate to muscle in on th
7/15/17 - Novel leukemia treatment could be 1st U.S. gene therapy
A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S.. A Food and Drug Administration advisory panel voted 10-0 on Wednesday in favor of the leukemia treatment developed by the University of Pennsylvania and Novartis Corp. The FDA usually follows recommendations from its expert panels, but isn't o
7/15/17 - OBI Pharma signs agreement with Abzena for ADC linker technology [Sport360]
UK- headquartered drug development technology and services provider Abzena plc, has signed a licensing agreement and a master services and clinical supply agreement with Taipei, Taiwan biotech OBI Pharma for its novel site-specific ThioBridge antibody drug conjugate linker technology to develop OBIs proprietary ADC, OBI-999 and a series of further
7/15/17 - One-window operation proposed for enhancing Pharma exports
Pakistan Pharmaceutical Manufacturers' Association has demanded the government to establish on emergency basis a one-window operation at the federal level and in provincial capitals to ease up all bureaucratic procedures and hurdles in the way of medicines' firms willing to do exports. Concerned speakers also demanded establishing a Pakistan-level.
7/15/17 - OPINION: How to think about the Senate's (latest) health care bill [Detroit Free Press]
July 15 Why should anyone care what I think about the Senate's latest proposal to repeal and replace Obamacare? And even if you're not as cynical as he is, it's fair to assume that my take on the Senate bill is shaped largely by my own values. So today, in lieu of passing judgement on a bill that is likely to undergo even further changes before i
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415